Pinned post
Shane Shapera
@shapps999
Clinician, Teacher, and ILD Program Director at the University of Toronto at the Toronto General Hospital
91 Following 482 Followers 352 Posts
Latest posts 5
Exciting news for patients living with progressive pulmonary fibrosis (#PPF). It looks like #nerandomilast is going to change the treatment landscape for both #IPF AND #PPF. 🥳 I can’t wait to see more details when the papers are published.
@jolenehfisher, @twhcmr and I were honored to have @drdayjee at our @UofTRespirology #ILD educational day. He gave a fantastic talk on genetics of ILD and biomarkers: past, present and future. Thanks @drdayjee for coming along the way to Toronto to enhance our event! 🙏🙏🙏
Congratulations to Dmitry Rozenberg and his team for their recent publication on the impact of frailty on outcomes after acute exacerbation of ILD.
pubmed.ncbi.nlm.nih.gov/38515270/
This work is supported by @THE_CPFF.
pubmed.ncbi.nlm.nih.gov/38515270/
This work is supported by @THE_CPFF.
@KerriBerriKerri @jolenehfisher @twhcmr @LeighMinuk @veronicasam940 @gilliangoobie @veronicasam940 @thelungdr @drstanbrook
@KerriBerriKerri @respandsleepjc So, the question is:View quoted post on X
Is RECITAL enough to solidify Rituximab in the ranks of mycophenolate and tocilizumab in the arsenal of immunosuppressive therapy you would use in #CTD-ILD?